- Home
- LEXX vs OPHC Comparison
LEXX vs OPHC Comparison
Compare LEXX & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- OPHC
- Stock Information
- Founded
- LEXX 2004
- OPHC 2000
- Country
- LEXX Canada
- OPHC United States
- Employees
- LEXX N/A
- OPHC N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- OPHC Major Banks
- Sector
- LEXX Health Care
- OPHC Finance
- Exchange
- LEXX Nasdaq
- OPHC Nasdaq
- Market Cap
- LEXX 49.3M
- OPHC 45.0M
- IPO Year
- LEXX N/A
- OPHC N/A
- Fundamental
- Price
- LEXX $3.02
- OPHC $4.54
- Analyst Decision
- LEXX Strong Buy
- OPHC Hold
- Analyst Count
- LEXX 2
- OPHC 1
- Target Price
- LEXX $11.00
- OPHC $5.25
- AVG Volume (30 Days)
- LEXX 97.0K
- OPHC 21.7K
- Earning Date
- LEXX 11-18-2024
- OPHC 11-07-2024
- Dividend Yield
- LEXX N/A
- OPHC N/A
- EPS Growth
- LEXX N/A
- OPHC 75.57
- EPS
- LEXX N/A
- OPHC 1.20
- Revenue
- LEXX $411,019.00
- OPHC $30,170,000.00
- Revenue This Year
- LEXX $82.02
- OPHC N/A
- Revenue Next Year
- LEXX $95.09
- OPHC N/A
- P/E Ratio
- LEXX N/A
- OPHC $3.79
- Revenue Growth
- LEXX 34.05
- OPHC 59.23
- 52 Week Low
- LEXX $0.90
- OPHC $3.12
- 52 Week High
- LEXX $6.85
- OPHC $4.98
- Technical
- Relative Strength Index (RSI)
- LEXX 43.57
- OPHC 44.70
- Support Level
- LEXX $2.91
- OPHC $4.50
- Resistance Level
- LEXX $3.39
- OPHC $4.63
- Average True Range (ATR)
- LEXX 0.20
- OPHC 0.07
- MACD
- LEXX -0.01
- OPHC -0.01
- Stochastic Oscillator
- LEXX 26.97
- OPHC 11.11
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.